A novel putative tyrosine kinase receptor encoded by the eph gene - PubMed (original) (raw)
. 1987 Dec 18;238(4834):1717-20.
doi: 10.1126/science.2825356.
Affiliations
- PMID: 2825356
- DOI: 10.1126/science.2825356
A novel putative tyrosine kinase receptor encoded by the eph gene
H Hirai et al. Science. 1987.
Abstract
Growth factors and their receptors are involved in the regulation of cell proliferation and also play a key role in oncogenesis. In this study, a novel putative kinase receptor gene, termed eph, has been identified and characterized by molecular cloning. Its primary structure is similar to that of tyrosine kinase receptors thus far cloned and includes a cysteine-rich region in the extracellular domain. However, other features of the sequence distinguish the eph gene product from known receptors with tyrosine kinase activity. Thus the eph protein may define a new class of these molecules. The eph gene is overexpressed in several human carcinomas, suggesting that this gene may be involved in the neoplastic process of some tumors.
Similar articles
- The c-erbB-2 gene encodes a receptor-like protein with tyrosine kinase activity.
Toyoshima K, Semba K, Akiyama T, Ikawa S, Yamamoto T. Toyoshima K, et al. Cold Spring Harb Symp Quant Biol. 1986;51 Pt 2:977-82. doi: 10.1101/sqb.1986.051.01.111. Cold Spring Harb Symp Quant Biol. 1986. PMID: 3472771 No abstract available. - Novel protein-tyrosine kinase cDNAs related to fps/fes and eph cloned using anti-phosphotyrosine antibody.
Letwin K, Yee SP, Pawson T. Letwin K, et al. Oncogene. 1988 Dec;3(6):621-7. Oncogene. 1988. PMID: 2485255 - A tyrosine kinase profile of prostate carcinoma.
Robinson D, He F, Pretlow T, Kung HJ. Robinson D, et al. Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5958-62. doi: 10.1073/pnas.93.12.5958. Proc Natl Acad Sci U S A. 1996. PMID: 8650201 Free PMC article. - Allosteric regulation of the epidermal growth factor receptor kinase.
Schlessinger J. Schlessinger J. J Cell Biol. 1986 Dec;103(6 Pt 1):2067-72. doi: 10.1083/jcb.103.6.2067. J Cell Biol. 1986. PMID: 3023396 Free PMC article. Review. No abstract available.
Cited by
- Master regulators of neurogenesis: the dynamic roles of Ephrin receptors across diverse cellular niches.
Rasool D, Jahani-Asl A. Rasool D, et al. Transl Psychiatry. 2024 Nov 6;14(1):462. doi: 10.1038/s41398-024-03168-4. Transl Psychiatry. 2024. PMID: 39505843 Free PMC article. Review. - COE targets EphA2 to inhibit vasculogenic mimicry formation induced by hypoxia in hepatocellular carcinoma.
Chen J, Dai SY, Wu S, Wu MK, Yu KK, Liu JC, Chang JY, Liu YQ. Chen J, et al. Front Pharmacol. 2024 Jul 10;15:1421470. doi: 10.3389/fphar.2024.1421470. eCollection 2024. Front Pharmacol. 2024. PMID: 39050762 Free PMC article. - The Clinical Relevance of the EPH/Ephrin Signaling Pathway in Pediatric Solid and Hematologic Malignancies.
Chatzikalil E, Stergiou IE, Papadakos SP, Konstantinidis I, Theocharis S. Chatzikalil E, et al. Int J Mol Sci. 2024 Mar 29;25(7):3834. doi: 10.3390/ijms25073834. Int J Mol Sci. 2024. PMID: 38612645 Free PMC article. Review. - EphB2 Receptor Promotes Dermal Fibrosis in Systemic Sclerosis.
Egal ESA, Kamdem SD, Yoshigi M, Yang CC, Pellizzari S, Kameni EM, Helms MN, Assassi S, Henkemeyer M, Frech TM, Mimche PN. Egal ESA, et al. Arthritis Rheumatol. 2024 Aug;76(8):1303-1316. doi: 10.1002/art.42858. Epub 2024 May 15. Arthritis Rheumatol. 2024. PMID: 38589317 - Targeting EphA2: a promising strategy to overcome chemoresistance and drug resistance in cancer.
Veiga RN, de Azevedo ALK, de Oliveira JC, Gradia DF. Veiga RN, et al. J Mol Med (Berl). 2024 Apr;102(4):479-493. doi: 10.1007/s00109-024-02431-x. Epub 2024 Feb 23. J Mol Med (Berl). 2024. PMID: 38393661 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous